We understand the level of rightful skepticism from the community given all previous failed big claims by others. There are many tests to tell you the risk of developing dementia, which is merely a "probability" number. Darmiyan's brain maps show (and measure) the actual pathology (neurodegeneration) in the brain, at microscopic resolution.

There is currently no other method to detect and quantify micro-structural abnormality in the brain at presymptomatic stages of dementia, which is one of the main reasons why all clinical trials of Alzheimer's test drugs keep failing one after another.

When a disease-modifying treatment is found using our technology (and practically impossible without it), the person who knows the status of their brain health will be the one to benefit most from the treatment before developing symptoms.